Literature DB >> 23828128

Sequential use of antiresorptives in younger women.

A Cano1, N Mendoza, R Sánchez-Borrego.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23828128     DOI： 10.1007/s00198-013-2436-0

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  6 in total

1.  Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale.

Authors:  E Oger
Journal:  Thromb Haemost       Date:  2000-05       Impact factor: 5.249

2.  Deaths: leading causes for 2002.

Authors:  Robert N Anderson; Betty L Smith
Journal:  Natl Vital Stat Rep       Date:  2005-03-07

3.  Cost-effectiveness of raloxifene in the UK: an economic evaluation based on the MORE study.

Authors:  J A Kanis; F Borgström; O Johnell; A Oden; D Sykes; B Jönsson
Journal:  Osteoporos Int       Date:  2004-07-24       Impact factor: 4.507

4.  Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and other factors.

Authors:  Peter Collins; Lori Mosca; Mary Jane Geiger; Deborah Grady; Marcel Kornitzer; Messan G Amewou-Atisso; Mark B Effron; Sherie A Dowsett; Elizabeth Barrett-Connor; Nanette K Wenger
Journal:  Circulation       Date:  2009-02-09       Impact factor: 29.690

Review 5.  Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data.

Authors:  Jack Cuzick; Ivana Sestak; Bernardo Bonanni; Joseph P Costantino; Steve Cummings; Andrea DeCensi; Mitch Dowsett; John F Forbes; Leslie Ford; Andrea Z LaCroix; John Mershon; Bruce H Mitlak; Trevor Powles; Umberto Veronesi; Victor Vogel; D Lawrence Wickerham
Journal:  Lancet       Date:  2013-04-30       Impact factor: 79.321

6.  European guidance for the diagnosis and management of osteoporosis in postmenopausal women.

Authors:  J A Kanis; E V McCloskey; H Johansson; C Cooper; R Rizzoli; J-Y Reginster
Journal:  Osteoporos Int       Date:  2012-10-19       Impact factor: 4.507
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.